150 related articles for article (PubMed ID: 12798307)
1. A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production.
Grosenbach DW; Schlom J; Gritz L; Gómez Yafal A; Hodge JW
Cell Immunol; 2003 Mar; 222(1):45-57. PubMed ID: 12798307
[TBL] [Abstract][Full Text] [Related]
2. A triad of costimulatory molecules synergize to amplify T-cell activation in both vector-based and vector-infected dendritic cell vaccines.
Schlom J; Sabzevari H; Grosenbach DW; Hodge JW
Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):193-228. PubMed ID: 12751840
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3).
Shankar P; Schlom J; Hodge JW
Vaccine; 2001 Dec; 20(5-6):744-55. PubMed ID: 11738738
[TBL] [Abstract][Full Text] [Related]
4. A triad of costimulatory molecules synergize to amplify T-cell activation.
Hodge JW; Sabzevari H; Yafal AG; Gritz L; Lorenz MG; Schlom J
Cancer Res; 1999 Nov; 59(22):5800-7. PubMed ID: 10582702
[TBL] [Abstract][Full Text] [Related]
5. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjögren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 1995; 15(3-4):235-53. PubMed ID: 8834450
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules.
Hodge JW; Grosenbach DW; Rad AN; Giuliano M; Sabzevari H; Schlom J
Vaccine; 2001 May; 19(25-26):3552-67. PubMed ID: 11348723
[TBL] [Abstract][Full Text] [Related]
7. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
Damle NK; Klussman K; Linsley PS; Aruffo A
J Immunol; 1992 Apr; 148(7):1985-92. PubMed ID: 1372018
[TBL] [Abstract][Full Text] [Related]
8. The primary alloresponse of human CD4+ T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression.
Hargreaves R; Logiou V; Lechler R
Int Immunol; 1995 Sep; 7(9):1505-13. PubMed ID: 7495758
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells.
Matsuoka N; Eguchi K; Kawakami A; Tsuboi M; Kawabe Y; Aoyagi T; Nagataki S
Clin Exp Immunol; 1996 Jun; 104(3):501-8. PubMed ID: 9099936
[TBL] [Abstract][Full Text] [Related]
10. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.
Semnani RT; Nutman TB; Hochman P; Shaw S; van Seventer GA
J Exp Med; 1994 Dec; 180(6):2125-35. PubMed ID: 7525848
[TBL] [Abstract][Full Text] [Related]
11. Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cells.
Yang S; Schlom J
Cancer Immunol Immunother; 2009 Apr; 58(4):503-15. PubMed ID: 18690438
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL.
Serghides L; Bukczynski J; Wen T; Wang C; Routy JP; Boulassel MR; Sekaly RP; Ostrowski M; Bernard NF; Watts TH
J Immunol; 2005 Nov; 175(10):6368-77. PubMed ID: 16272289
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines.
Kudo-Saito C; Hodge JW; Kwak H; Kim-Schulze S; Schlom J; Kaufman HL
Vaccine; 2006 Jun; 24(23):4975-86. PubMed ID: 16621183
[TBL] [Abstract][Full Text] [Related]
14. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
15. Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules enhances the frequency of activation of single murine CD4+ and CD8+ T cells and induces synthesis of IL-3 and IFN-gamma but not IL-4 or IL-6.
Maraskovsky E; Troutt AB; Kelso A
Int Immunol; 1992 Apr; 4(4):475-85. PubMed ID: 1350461
[TBL] [Abstract][Full Text] [Related]
16. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
17. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
18. Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules.
Hodge JW; Rad AN; Grosenbach DW; Sabzevari H; Yafal AG; Gritz L; Schlom J
J Natl Cancer Inst; 2000 Aug; 92(15):1228-39. PubMed ID: 10922408
[TBL] [Abstract][Full Text] [Related]
19. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
20. Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs.
Kufer P; Zettl F; Borschert K; Lutterbüse R; Kischel R; Riethmüller G
Cancer Immun; 2001 Nov; 1():10. PubMed ID: 12747771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]